drugmaker

Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines.Bloomberg | Bloomberg | Getty ImagesNovartis shares jumped on Tuesday after the Swiss drugmaker raised…

BEIJING : Global drugmaker AstraZeneca will seek to be a patriotic company in China that "loves the Communist Party", its China president said at an event on Friday. Wang Lei, who is also the company's global executive vice president,…

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumour cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen…

SELF-RATIONING INSULIN The cost of a five-pack of Humalog is currently US$530.40, although the out-of-pocket price to a user varies depending on one's insurance plan. Average monthly use varies by user, Eli Lilly says on its website. Drug…

Eli Lilly and Co., one of the largest drug manufacturers in the world, announced Wednesday that it will cut prices for some of its most commonly prescribed insulin products — a move that could potentially provide instant relief to…

Drugmaker Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions. The moves, announced on Wednesday, promise critical relief to many…

‘Gift-giving’ – from free dinners and drug samples to promotional merchandise – seems to be driving drugmakers’ marketing – a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical…

The Mount Sinai Health System began an effort this week to build a vast database of patient genetic information that can be studied by researchers — and by a large pharmaceutical company.The goal is to search for treatments for illnesses…

<!-- -->Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groupsDrugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy…

American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion. With the agreement, Pfizer, one of the top…